CVS Health Co. (NYSE:CVS) Position Boosted by Patriot Financial Group Insurance Agency LLC

Patriot Financial Group Insurance Agency LLC lifted its position in CVS Health Co. (NYSE:CVS) by 35.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 21,240 shares of the pharmacy operator’s stock after buying an additional 5,569 shares during the quarter. Patriot Financial Group Insurance Agency LLC’s holdings in CVS Health were worth $1,677,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in CVS. Bryn Mawr Capital Management LLC grew its holdings in shares of CVS Health by 74.0% during the third quarter. Bryn Mawr Capital Management LLC now owns 43,213 shares of the pharmacy operator’s stock worth $3,017,000 after purchasing an additional 18,385 shares during the last quarter. Value Partners Investments Inc. raised its position in CVS Health by 26.5% in the 3rd quarter. Value Partners Investments Inc. now owns 991,601 shares of the pharmacy operator’s stock valued at $69,261,000 after buying an additional 207,702 shares during the last quarter. Sonora Investment Management Group LLC grew its stake in CVS Health by 1.6% in the third quarter. Sonora Investment Management Group LLC now owns 50,488 shares of the pharmacy operator’s stock valued at $3,525,000 after purchasing an additional 774 shares in the last quarter. Checchi Capital Advisers LLC grew its stake in CVS Health by 2.3% in the third quarter. Checchi Capital Advisers LLC now owns 10,405 shares of the pharmacy operator’s stock valued at $726,000 after purchasing an additional 233 shares in the last quarter. Finally, Personal CFO Solutions LLC grew its stake in CVS Health by 2.6% in the third quarter. Personal CFO Solutions LLC now owns 19,355 shares of the pharmacy operator’s stock valued at $1,351,000 after purchasing an additional 491 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Insider Buying and Selling at CVS Health

In related news, EVP Prem S. Shah sold 29,473 shares of the stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the completion of the sale, the executive vice president now owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 0.25% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on CVS. Barclays initiated coverage on CVS Health in a research note on Wednesday, March 6th. They issued an “equal weight” rating and a $78.00 price target for the company. HSBC assumed coverage on shares of CVS Health in a research report on Friday, December 22nd. They set a “buy” rating and a $94.00 target price for the company. Royal Bank of Canada cut their price target on CVS Health from $86.00 to $84.00 and set an “outperform” rating on the stock in a report on Thursday, February 8th. StockNews.com cut CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. Finally, Leerink Partnrs reiterated an “outperform” rating on shares of CVS Health in a report on Monday, February 26th. Four research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $90.21.

CVS Health Stock Performance

Shares of CVS traded up $0.33 during mid-day trading on Friday, reaching $79.76. The company had a trading volume of 8,981,310 shares, compared to its average volume of 9,174,262. CVS Health Co. has a 52-week low of $64.41 and a 52-week high of $83.25. The company has a quick ratio of 0.63, a current ratio of 0.86 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $100.37 billion, a P/E ratio of 12.35, a PEG ratio of 1.05 and a beta of 0.51. The stock has a 50 day moving average of $75.78 and a two-hundred day moving average of $73.51.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, topping analysts’ consensus estimates of $2.01 by $0.11. The company had revenue of $93.81 billion during the quarter, compared to analysts’ expectations of $90.58 billion. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. CVS Health’s quarterly revenue was up 11.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.99 EPS. On average, analysts expect that CVS Health Co. will post 8.33 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Monday, April 22nd will be issued a $0.665 dividend. The ex-dividend date is Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a yield of 3.34%. CVS Health’s payout ratio is 41.18%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.